500 Shares in CVS Health Co. (NYSE:CVS) Purchased by Legacy Investment Solutions LLC

Legacy Investment Solutions LLC purchased a new position in CVS Health Co. (NYSE:CVS) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 500 shares of the pharmacy operator’s stock, valued at approximately $31,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the third quarter worth $25,000. Livelsberger Financial Advisory bought a new position in shares of CVS Health during the 3rd quarter valued at about $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health during the third quarter valued at about $32,000. Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the third quarter worth about $33,000. Finally, ORG Partners LLC lifted its position in shares of CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 592 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Mizuho cut their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Barclays dropped their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Finally, TD Cowen upped their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $70.50.

CVS Health Stock Performance

CVS stock opened at $55.29 on Monday. The firm has a market cap of $69.58 billion, a price-to-earnings ratio of 14.03, a PEG ratio of 0.95 and a beta of 0.54. CVS Health Co. has a twelve month low of $52.71 and a twelve month high of $83.25. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The business’s fifty day simple moving average is $59.32 and its two-hundred day simple moving average is $58.79.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the business posted $2.21 EPS. Analysts predict that CVS Health Co. will post 5.32 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a yield of 4.81%. CVS Health’s payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.